A serology-based approach combined with clinical examination of 125 Ro/SSA-positive patients to define incidence and prevalence of subacute cutaneous lupus erythematosus

Arthritis and Rheumatism

Volumn 56, Issue 1, 2007, Pages 255-264

  Popovic, Karin ^a,c   Nyberg, Fredrik ^a,b   Wahren Herlenius, Marie ^a   Nyberg, Filippa ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b ASTRAZENECA R AND D   (Sweden)

^c DANDERYD HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; AUTOIMMUNE DISEASE; CARDIOVASCULAR DISEASE; CLINICAL EXAMINATION; COMORBIDITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INCIDENCE; LUPUS ERYTHEMATOSUS; MAJOR CLINICAL STUDY; MALE; PHOTODERMATOSIS; PHOTOSENSITIVITY; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; SELF REPORT; SEROLOGY; SKIN DISEASE; SKIN LUPUS ERYTHEMATOSUS; SKIN MANIFESTATION; SWEDEN; SYMPTOM;

AGE DISTRIBUTION; FEMALE; HUMANS; INCIDENCE; LUPUS ERYTHEMATOSUS, CUTANEOUS; MALE; PHOTOSENSITIVITY DISORDERS; PREVALENCE; QUESTIONNAIRES; RIBONUCLEOPROTEINS; SEROEPIDEMIOLOGIC STUDIES; SEX DISTRIBUTION; SWEDEN;

EID: 33846195400     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.22286     Document Type: Article

References (29)

1. Sontheimer RD, Thomas JR, Gilliam JN. Subacute cutaneous lupus erythematosus: a cutaneous marker for a distinct lupus erythematosus subset. Arch Dermatol 1979;115:1409-15.
2. Callen JP, Klein J. Subacute cutaneous lupus erythematosus: clinical, serologic, immunogenetic, and therapeutic considerations in seventy-two patients. Arthritis Rheum 1988;31:1007-13.
3. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
4. Gilliam JN, Sontheimer RD. Distinctive cutaneous subsets in the spectrum of lupus erythematosus. Am Acad Dermatol 1981;4:471-5.
5. Sontheimer RD, Maddison PJ, Reichlin M, Jordon RE, Stastny P, Gilliam JN. Serologic and HLA associations in subacute cutaneous lupus erythematosus, a clinical subset of lupus erythematosus. Ann Intern Med 1982;97:664-71.
6. Chlebus E, Wolska H, Blaszczyk M, Jablonska S. Subacute cutaneous lupus erythematosus versus systemic lupus erythematosus: diagnostic criteria and therapeutic implications. J Am Acad Dermatol 1998;38:405-12.
7. Lee LA, Roberts CM, Frank MB, McCubbin VR, Reichlin M. The autoantibody response to Ro/SSA in cutaneous lupus erythematosus. Arch Dermatol 1994;130:1262-8.
8. Srivastava M, Rencic A, Diglio G, Santana H, Bonitz P, Watson R, et al. Drug-induced, Ro/SSA-positive cutaneous lupus erythematosus. Arch Dermatol 2003;139:45-9.
9. Nyberg F, Hasan T, Puska P, Stephansson E, Hakkinen M, Ranki A, et al. Occurrence of polymorphous light eruption in lupus erythematosus. Br J Dermatol 1997;136:217-21.
10. Millard TP, Kondeatis E, Cox A, Wilson AG, Grabczynska SA, Carey BS, et al. A candidate gene analysis of three related photosensitivity disorders: cutaneous lupus erythematosus, polymorphic light eruption and actinic prurigo. Br J Dermatol 2001;145:229-36.
11. Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, et al. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002;61:554-8.
12. Mosca M, Neri R, Bencivelli W, Tavoni A, Bombardieri S. Undifferentiated connective tissue disease: analysis of 83 patients with a minimum followup of 5 years. J Rheumatol 2002;29:2345-9.
13. Tebbe B, Orfanos CE. Epidemiology and socioeconomic impact of skin disease in lupus erythematosus. Lupus 1997;6:96-104.
14. Fritzler MJ, Pauls JD, Kinsella TD, Bowen TJ. Antinuclear, anticytoplasmic, and anti-Sjögren's syndrome antigen A (SS-A/Ro) antibodies in female blood donors. Clin Immunol Immunopathol 1985;36:120-8.
15. Nived O, Sturfelt G, Wollheim F. Systemic lupus erythematosus in an adult population in southern Sweden: incidence, prevalence and validity of ARA revised classification criteria. Br J Rheumatol 1985;24:147-54.
16. Rothman, Greenland. Modern epidemiology. 2nd ed. Philadelphia: Lippincott-Raven; 1998. p. 43-4.
17. Sontheimer RD. Subacute cutaneous lupus erythematosus: a decade's perspective. Med Clin North Am 1989;73:1073-90.
18. Weinstein C, Miller MH, Axtens R, Littlejohn GO, Dorevitch AP, Buchanan R. Lupus and non-lupus cutaneous manifestations in systemic lupus erythematosus. Aust NZJ Med 1987;17:501-6.
19. Ros AM, Wennersten G. Current aspects of polymorphous light eruptions in Sweden. Photodermatol 1986;3:298-302.
20. Pao C, Norris PG, Corbett M, Hawk JL. Polymorphic light eruption: prevalence in Australia and England. Br J Dermatol 1994;130:62-4.
21. Roguedas AM, Misery L, Sassolas B, Le Masson G, Pennec YL, Youinou P. Cutaneous manifestations of primary Sjogren's syndrome are underestimated. Clin Exp Rheumatol 2004;22:632-6.
22. Werth VP, Bashir M, Zhang W. Photosensitivity in rheumatic diseases. J Investig Dermatol Symp Proc 2004;9:57-63.
23. Millard TP, Kondeatis E, Vaughan RW, Lewis CM, Khamashta MA, Hughes GR, et al. Polymorphic light eruption and the HLA DRB1*0301 extended haplotype are independent risk factors for cutaneous lupus erythematosus. Lupus 2001;10:473-9.
24. Norris P, Hawk JL. The idiopathic photodermatoses: polymorphic light eruption, actinic prurigo, and hydroa vacciniforme. In: Hawk JL, editor. Photodermatology. London: Arnold; 1998. p. 102-11.
25. Hagforsen E, Edvinsson M, Nordlind K, Michaelsson G. Expression of nicotinic receptors in the skin of patients with palmoplantar pustulosis. Br J Dermatol 2002;146:383-91.
26. Hassan AB, Lundberg IE, Isenberg D, Wahren-Herlenius M. Serial analysis of Ro/SSA and La/SSB antibody levels and correlation with clinical disease activity in patients with systemic lupus erythematosus. Scand J Rheumatol 2002;31:133-9.
27. Simmons-O'Brien E, Chen S, Watson R, Antoni C, Petri M, Hochberg M, et al. One hundred anti-Ro (SS-A) antibody positive patients: a 10-year follow-up. Medicine (Baltimore) 1995;74:109-30.
28. Wolpert KA, Webster AD, Whittaker SJ. Discoid lupus erythematosus associated with a primary immunodeficiency syndrome showing features of non-X-linked hyper-IgM syndrome. Br J Dermatol 1998;138:1053-7.
29. Powell FC, Greipp PR, Su WP. Discoid lupus erythematosus and monoclonal gammopathy. Br J Dermatol 1983;109:355-60.